同興環保(003027.SZ):擬約6億元投建年產2萬噸鈉離子電池正極材料
格隆匯11月10日丨同興環保(003027.SZ)公佈,鑑於雙方發展需要,同興環保科技股份有限公司(“乙方”)與安徽含山經濟開發區管理委員會(簡稱“甲方”)簽訂了《投資合作協議書》。根據國家有關法律法規和政策規定,甲乙雙方本着平等、自願、有償、誠實信用的原則,訂立該協議,相關投資項目為年產2萬噸鈉離子電池正極材料。項目總投資約6億元。
該項目新購砂磨機、噴霧乾燥機、除鐵器等設備200餘台套,主要從事鈉離子電池正極材料等產品的生產和銷售,產品廣泛應用於低速車、啟動電源及儲能等領域。項目全部投產後,可實現年產20,000噸鈉離子正極材料產能。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.